Filing metadata

Accession number
0001127602-23-004506
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Feb 10, 2023
Reporting period
Feb 08, 2023
Description
Insider transaction

Explore SEC Filings Hub